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Abstract
Purpose Percutaneous coronary intervention (PCI) is a com-
mon invasive procedure for the treatment of coronary artery
diseases. Long-term cognitive functioning after PCI and its
association with health-related quality of life (HRQL) and
psychological factors is relatively unknown. The aim of this
study is to examine whether perceived cognitive functioning
during the year after PCI is associated with HRQL over this
time period, and whether mood, fatigue, and age are associat-
ed with changes in perceived cognition and HRQL.
Methods Patients undergoing PCI (n = 384, 79% male, mean
age = 63, SD = 10) were recruited in the observational Tilburg
Health Outcome Registry of Emotional Stress after Coronary
Intervention (THORESCI) cohort study. Perceived concentra-
tion and attention problems, HRQL, mood, and fatigue were
assessed at baseline, at 1-month and 12-month follow-up.
Results General linear mixed modeling analysis showed that
across time, between- and within-subject differences in per-
ceived concentration problems were associated with a reduced
HRQL in all domains independent of clinical and demograph-
ic covariates. Only a part of this association could be ex-
plained by negative mood, fatigue, and older age. Similar
findings were found for between-subject differences in per-
ceived attention problems.
Conclusions Between-subject differences and within-subject
changes in perceived cognition in PCI patients were strongly
associated with HRQL across time, such that poorer perceived
cognition was associated with poorer HRQL, independent of
demographic and clinical variables. Most of the associations
were also independent ofmood and fatigue. The results should
increase the awareness of clinicians for the role of cognition in
the cardiac rehabilitation and recovery post-PCI.
Keywords Age . Cognition . Fatigue .Mood . Percutaneous
coronary intervention . Quality of life
Introduction
Health-related quality of life (HRQL) is considered an impor-
tant indicator of health outcome after percutaneous coronary
intervention (PCI) [1, 2]. Greater severity of coronary artery
diseases (CAD) [3], symptoms of depression and fatigue [4],
and reduced cognitive functioning [5] have been related to
decreased HRQL.
Cognitive functioning is an intellectual process by which
one becomes aware of, perceives, or comprehends ideas, and
it involves mental processes such as perception, thinking, rea-
soning, and remembering [6]. Research has focused on the
cognitive effects of carotid artery treatments [7, 8], but less
is known about these effects following PCI [9–11] or coronary
artery bypass graft (CABG) [9–13] with inconsistent findings,
varying from no to severe impairments in concentration, at-
tention, memory , and psychomotor speed after treatment
[12–14]. Some studies have examined cognitive problems af-
ter CABG as compared to PCI 1 year after treatment [10, 11,
13, 15]. Because PCI patients were not examined as the main
study group in these studies, the current study will investigate
the extent and course of cognitive complaints after PCI.
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Notwithstanding well-known benefits, neuropsychological
testing to assess cognitive function often is not feasible or
affordable in clinical settings [16]. In recent years studies
(e.g., [16]) have been advocating the use of self-reported per-
ceived cognitive function as a screening and stratification tool.
This is supported by studies showing that perceived cognitive
function may predict changes in brain function and may pre-
cede more overt deficits [17].
Both perceived and neuropsychologically assessed cogni-
tive functioning is found to be a major determinant of HRQL
in patients with CAD [5] and following CABG [18].
However, this association cannot be examined without taking
into account several clinical factors. Although age is an im-
portant risk factor for both CAD [19] and cognitive decline
[6], it is uncertain whether it is an independent factor for
predicting HRQL [20]. Evidence also suggests that depressive
mood and fatigue are associated with both cognitive com-
plaints and poor outcome in patients with CAD, including
decreased HRQL [4, 21].
Because there is a paucity of studies on long-term per-
ceived cognitive functioning after PCI, the current study ex-
amined perceived cognitive functioning immediately after
PCI and at 1-year follow-up, and its association with HRQL.
We also examined whether symptoms of depression and fa-
tigue are associated with changes in perceived cognition and
HRQL, andmay (partially) explain the link between perceived
cognition and HRQL. Finally, we examined whether age is
associated with changes in perceived cognition and HRQL
[6].
Methods
Patient Population and Procedure—THORESCI Study
The current study was part of an ongoing prospective cohort
study, TilburgHealthOutcomesRegistry ofEmotional Stress
afterCoronary Intervention (THORESCI), which recruits par-
ticipants from the clinical standard of care PCI Registry at the
Elisabeth-TweeSteden Hospital in Tilburg, the Netherlands.
All patients scheduled for elective or acute PCI for ≥1 coro-
nary occlusions were included, provided that patients were
aged ≥18 and had sufficient understanding of the Dutch lan-
guage to fill out questionnaires. Medical records were checked
to see whether patients had a life threatening comorbidity
(e.g., metastasized cancer) or cognitive disorder (i.e., dementia
or Alzheimer’s), and if so, they were excluded. On the day of
the PCI, patients were approached by a member of the re-
search team who explained the study content and its require-
ments. After giving written consent, the patients were asked to
fill out a psychosocial survey at home, between 0 and 5 days
after PCI (inclusion (baseline)), and at 1, and 12 months post-
PCI by e-mail or on paper. The study protocol is in keeping
with the Helsinki declaration and was approved by the insti-
tutional medical ethics review board.
Measures
Demographics
Age, gender, and education level were obtained from self-
report questionnaires at inclusion (T0). Educational level
was recoded into a dichotomous variable—high education
(at least high school) vs. low education.
Perceived Cognitive Functioning
Perceived concentration was measured with dedicated ques-
tions. From the Patient Health Questionnaire (PHQ-9) [22],
the question asking to report on diminished ability to think or
concentrate, or more indecisiveness [23], i.e., BTrouble con-
centrating on things, such as reading the newspaper or
watching television?,^ was used. This item was rated on a
Likert scale from 0 (Bnot at all^) to 3 (Balmost every day^)
[22]. From the World Health Organization Quality of Life
assessment instrument (WHOQOL-Bref) [24], we used
BHow well are you able to concentrate^ to assess perceived
concentration. This item was rated on a Likert scale from 1
(Bnot at all^) to 5 (Bextremely^) [24]. We excluded the item
from the quality of life assessment (see below). The scores of
this item were reversed for this study for it to correspond with
the scores of the PHQ-9. To calculate the total perceived con-
centration score, these two questions were standardized and
summed to generate a total concentration score, with a higher
score indicating worse concentration. The range for the stan-
dardized scores was on a Likert scale from −1 to 3, with a
mean of 0. Internal consistency in this study was acceptable
(Cronbach’s alpha Baseline = 0.67; 1month = 0.81; 12months
= 0.80).
Perceived attention was measured with the facet Bacting
with awareness^ from the short form of the Five Facet
Mindfulness Questionnaire (TFMQ-SF); e.g., BI do jobs or
tasks automatically, without being aware of what I am doing^;
BI find myself doing things without paying attention^ [25].
Items were scored on a 5-point Likert-type scale ranging from
1 (Bnever or rarely true^) to 5 (Bvery often or always true^)
[25], with higher scores indicating worse attention. Total score
was calculated by computing the mean of the scores on the
five items per measurement moment. In this study, internal
consistency was good (Cronbach’s alpha Baseline = 0.77;
1 month = 0.80; 12 months = 0.84).
Health-Related Quality of Life
The World Health Organization Quality of Life assessment
instrument (WHOQOL-Bref), a reliable and valid
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questionnaire, was used to measure HRQL [24]. Its 26 items
are rated on a Likert scale from 1 (Bvery poor/not at all/very
dissatisfied/never^) to 5 (Bvery good/extremely/very satisfied/
always^) that represent one facet (BGeneral health and overall
quality of life^), and four domains (BPhysical health^,
BPsychological health^, BSocial relationships^, and
BEnvironment^). In the present study, question 7 BHow well
are you able to concentrate^, was removed from the score of
its domain (BPsychological health^) because it is already used
to measure perceived concentration. The scores on the other
domains are unaffected by this action.
Depressive Symptoms
The Beck Depression Inventory (BDI) was used to measure
somatic-affective and cognitive-affective symptoms of depres-
sion [26]. The BDI consists of 21 items with 4 scores per item
ranging fromBnormal^ to Bsevere depressed^ state [26].
Questions in this instrument refer to the past week. In this study,
internal consistency was good (Cronbach’s alpha = 0.87).
Fatigue
Fatigue was assessed with fatigue subscale of the 24-item
Health Complaints Scale (HCS). This questionnaire has high
internal consistency (Cronbach’s α > 0.89), adequate test-retest
reliability (r > 0.69), and good construct validity [27]. The
fatigue subscale consisted of four items, which were summed,
with higher scores indicating more fatigue complaints. In the
current dataset, Cronbach’s alpha was >0.80. All items are rated
on a Likert scale from 0 (Bnot at all^) to 4 (Ba lot^).
Medical Covariates
At inclusion, the patient’s medical records were used to obtain
information on the indication for PCI. PCI as invasive treat-
ment of acute coronary syndrome were compared to patients
with elective PCI.
Cardiac history (heart failure, previous MI, previous CABG,
single vs. multi-vessel disease), medication use (antidepressants,
beta-blockers, antiplatelet drugs, anticoagulant drugs, ACE in-
hibitors, calcium antagonists), and risk factors (family history of
CAD, hypercholesterolemia, and diabetes mellitus type 2) were
taken from the patient’s medical records at inclusion (T0).




First, we calculated median splits for the longitudinal person-
mean of the concentration and attention problems scores for
presentation purposes and to examine baseline differences in
patient characteristics between patients with and without per-
ceived concentration or attention complaints. If patients were
exactly at the median, they were included as low attention/
concentration complaints. Student’s t tests were then done in
case of continuous variables, and chi-square tests in case of
categorized variables to compare the groups.
HRQL Change over Time
To assess whether HRQL changed significantly over time,
time was included as the only predictor in the first step of
the general linear mixed modeling analysis (see explanation
below). To compare low vs. high concentration/attention
groups in terms of HRQL change over time, the mean scores
and standard deviations of the groups on HRQL in the three
time periods were calculated.
General Linear Mixed Modeling Analysis
General linear mixed modeling analysis was performed to
examine the effects of the level and change of perceived cog-
nition over time on the course of HRQL over the 12-month
follow-up period, using maximum likelihood estimation, and
an unstructured covariance matrix with a two-level structure
(i.e., repeated measurement occasions (lower level), partici-
pant (higher level)). This technique is suitable for analysis of
repeated measurements, as it takes the possibility of correlated
data into account. In addition, in contrast to traditional repeat-
ed measures ANOVA, one missing measurement occasion
does not automatically lead to exclusion of that patient from
analysis, limiting bias and preserving statistical power.
Another advantage to linear mixed modeling analysis is the
possibility of measuring variables as fixed variables or as
time-varying variables.
Person—means of both perceived concentration and atten-
tion complaints scores over the three included measurement
occasions were calculated first (between-subjects effects), and
then the deviation from this person—mean at each time point
was calculated in order to get information on the person-
specific change in perceived concentration and attention com-
plaints (within subjects effects). These continuous variables
constituted our independent variables. Five separate analyses
were done for each HRQL domain, and analyses were per-
formed separate for perceived concentration and perceived
attention. In step 1, the two concentration complaints variables
(person—mean and deviation) were entered (Unadjusted
model). In step 2, the models were adjusted for demographics
(gender, education) and medical covariates (PCI indication,
cardiac history, antidepressant use). In the third step, we added
depressive symptoms and fatigue, and finally age was added
to the model. The same steps were taken for perceived atten-
tion complaints scores. All demographic variables and
Int.J. Behav. Med.
medical covariates were included as fixed variables.
Depressive symptoms and fatigue were added as time-
varying variables. All statistical analyses were performed
using SPSS 22 (IBM SPSS Statistics for Windows, Version
22. Armonk, NY: IBM Corps USA). To prevent Type I error




In this ongoing cohort study, a subsample of the THORESCI
study was used in which all participants were required to have
filled out theWHOQOL-Bref and/or PHQ-9 and TFMQ-SF in
order to be included in the final analysis set. Therefore, based
on the data extraction of February 2016, we included 384
Baseline assessments, 354 1-month assessments, and 233
12-months assessments in our analyses (Mage 63.44, SD
10.69 years, 79.0% Men). The considerably lower number
of participants assessed at 12 months is explained by the cur-
rent study being an ongoing cohort study. The statistical tech-
nique we chose is robust for such a decline though. A total of
17.2% of participants included at baseline had dropped out at
12-month follow-up (n = 55), or had deceased within that
timeframe (n = 10). In comparing the included sample with
the dropouts/deceased sample on baseline characteristics, re-
sults showed that the dropouts/deceased were older (p = .006),
more often had heart failure (p = .038), and reported higher
scores of depression (p = .033).
Baseline sample characteristics are presented in Table 1.
With respect to demographic characteristics, patients with
above median scores of total perceived concentration com-
plaints (n = 190) were significantly younger (p = .034).
Patients with perceived concentration complaints were more
often on anti-depressants (p = .024) and more often underwent
an acute PCI (p = .019). In addition, patients with perceived
concentration and attention complaints reported higher scores
of depression (p < .001) and fatigue (p < .001).
Change of Health Related Quality of Life over Time
As the initial analysis, General health and overall QoL im-
proved significantly over the 12-month follow-up period
(F = 9.80, p < .001) (first table line, Table 2). General health
and overall QoL did not improve at 1 month (p = .222), but
significantly improved at 12 months compared to baseline
(p < .001) and 1-month follow-up (p < .001). The physical
subdomain score also showed a main effect of time
(F = 23.33, p < .001). Physical health improved significantly
at 1-month follow-up (p < .001) and 12-month follow-up
(p < .001), compared to baseline. A significant improvement
between 1-month follow-up and 12-month follow-up was also
found (p = .03). Social relationship scores showed a main
effect of time as well (F = 3.13, p = .045). Between baseline
and 1-month follow-up, no significant improvement was
found (p = .921); however, between baseline/1 month and
12-month follow-up, a significant decline was found
(p = .029, p = .016). Psychological health and environment
scores showed no main effect of time (F = 1.88, p = .155; and
F = .165, p = .848 respectively).
Because concentration and attention were only moderately
correlated (r = 0.30), further analyses were performed sepa-
rately for perceived concentration complaints scores and at-
tention complaints.
Figure 1 shows that the mean scores of all the HRQL do-
mains over time for low concentration/attention complaints
are higher than high concentration/attention complaints. In
addition, scores on general health and overall QoL and the
physical domain increase over time in all groups, while
HRQL scores on other domains remain stable over time
(Fig. 1).
Concentration and HRQL
Results showed a main effect of between-subject differences
in perceived concentration complaints on general health and
overall QoL (F = 118.22, p < .001), and of within-subject
differences in perceived concentration complaints scores as
well (F = 15.19, p < .001). These main effects of between-
and within-subject differences in concentration were similar
for physical health (F = 129.72, p < .001; F = 40.31, p < .001),
psychological health (F = 160.10, p < .001; F = 20.63,
p = .001), and environment (F = 74.88, p < .001; F = 9.11,
p = .003). For social relationships, the between-subject differ-
ences in concentration were significant (F = 77.30, p < .001);
however, the within-subject differences were found with a
significance level between p = .01 and p = .05. Estimates are
shown in Table 2, which represents the unstandardized regres-
sion coefficients of the dependent variable when the indepen-
dent variable increases with one unit.
In unadjusted analyses, better perceived concentration
was associated with better general health and overall QoL
over time (p < .001), for between- as well as within-subject
differences. Similar effects remained when adjusting for
demographic and clinical covariates. None of the demo-
graphic or clinical covariates were associated with general
health and overall QoL across time. A substantial part of
the relation between perceived concentration complaints
and HRQL was explained by depressive mood (p < .001)
and fatigue (p < .001; Step 3); however, results showed that
increased perceived concentration complaints remained a
predictor for worse general health and overall QoL. The
same results showed when age (p = .007) was added to
the model in a final step.
Int.J. Behav. Med.
Between- and within-subject differences in perceived con-
centration complaints were also related to differences in phys-
ical health over time, which remained the same in the adjusted
analyses. Male gender was associated with better physical
health, and antidepressant use tended to be associated with
poorer physical health. Based on the reduction in estimates
in step 3, depressivemood and fatigue only partially explained
the relation between perceived concentration complaints and
physical health. Age did not contribute to this association.
Between- and within-subject differences in concentration
complaints were associated with psychological health, social
relationships, and environment. These effects remained in the
adjusted analyses. In the third step, it was shown that higher
depressed mood was strongly related to poorer psychological
health, social relationships, and environment, but fatigue was
not associated with social relationships (p = .102) or environ-
ment (p = .022). However, with respect to between-subject
differences, more perceived concentration complaints
remained a predictor of poorer HRQL in the three domains,
even though strong reductions in estimates were observed.
Within-subject changes were only significantly related to psy-
chological health and environment after controlling for psy-
chological factors. Older age was associated with better psy-
chological health, while age did not affect social relationships.
Again, more perceived concentration complaints remained a
predictor of poorer HRQL in the three domains.
Attention and HRQL
There was a significant between-subjects effect of perceived
attention complaints (F = 46.86, p < .001) and a significant
within-subjects effect (F = 8.51, p = .004), both reflecting
increased attention complaints being associated with poorer
HRQL (Table 3). For the domain scores, this main between-
subjects effect of perceived attention complaints was also
found (physical F = 47.22, p < .001; psychological
Table 1 Baseline patient characteristics























Sex (male) 79.9% (155) 77.9% (148) 0.23 .631 82.1% (161) 76.1% (137) 2.08 .150
Age mean (SD) 64.63 (8.99) 62.53 (10.33) 4.53 .034 64.09 (9.22) 62.94 (10.12) 1.34 .248
High education (≥8 years)b 69.2% (126) 67.4% (122) 2.07 .355 64.8% (118) 72.7% (128) 5.25 .072
Medical
Cardiac historyc
Heart failure 2.7% (5) 2.1% (4) 0.12 .730 2.1% (4) 2.3% (4) 0.02 .900
MI 15.1% (28) 21.9% (41) 2.92 .087 15.7% (30) 20.0% (35) 1.15 .283
CABG 7.0% (13) 8.0% (15) 0.14 .705 7.9% (15) 6.9% (12) 0.13 .716
Risk factors
Genetic riskc 40.5% (75) 43.9% (82) 1.05 .518 38.2% (73) 47.1% (82) 2.96 .086
Hypercholesterolemiac 36.8% (68) 36.9% (69) 0.00 .977 35.6% (68) 38.5% (67) 0.33 .566
Diabetes mellitus type 2 13.4% (26) 11.1% (21) 0.49 .482 14.3% (28) 8.9% (16) 2.65 .104
Medication used
Antidepressants 3.2% (6) 8.6% (16) 4.77 .024 5.8% (11) 5.1% (9) 0.07 .796
Beta-blockers 33.9% (63) 38.5% (72) 0.87 .352 34.6% (66) 37.1% (65) 0.27 .606
Antiplatelet drugs 43.0% (80) 42.8% (80) 0.00 .964 41.9% (80) 43.4% (76) 0.09 .765
Anticoagulant drugs 5.9% (11) 7.0% (13) 0.17 .683 7.9% (15) 5.1% (9) 1.10 .295
ACE inhibitors 34.4% (64) 40.6% (76) 1.55 .214 35.1% (67) 39.4% (69) 0.74 .390
Calcium antagonists 14.0% (26) 15.5% (29) 0.17 .677 16.2% (31) 12.0% (21) 1.34 .247
PCI
Acute 60.8% (118) 72.1% (137) 5.48 .019 65.3% (128) 68.9% (124) 0.55 .460




7.19 (4.33) 11.35 (7.33) 43.10 <.001 7.53 (4.39) 11.16 (7.50) 31.38 <.001
Fatigue mean (SD) 3.96 (3.65) 6.35 (4.56) 29.93 <.001 4.19 (3.92) 6.08 (4.45) 17.85 <.001
Bold p values indicate statistical significance, italic p values indicate significance on a trend level





F = 71.91, p < .001; social F = 44.67, p < .001; environment
F = 37.87, p < .001). The main within-subjects effect of per-
ceived attention complaints was only found for the physical
component (F = 5.58, p = .018), indicating that physical health
changes within a person covaries with changes in perceived
attention complaints over time.
When adding clinical and demographic covariates, the re-
lation between attention and general health and overall QoL
remained similar. In step 3, both depressive symptoms and
fatigue were strongly related to general health and overall
QoL (p < .001), and may partially explain this effect, based
on the reduction of the attention complaints estimate and the
reduction of the significance level (p = .028). Older age was
significantly associated with better general health and overall
QoL (p = .006), and further reduced the association between
attention and general health and overall QoL.
Between-subjects differences in perceived attention com-
plaints were significantly related to differences in all HRQL
domains, and within-subjects differences in perceived atten-
tion complaints were only significantly related to differences
in physical health over time. In adjusted analyses, these effects
remained in the psychological, social relationship, and envi-
ronment domains. Depressive symptoms were associated with
poorer HRQL in all domains, and fatigue with poorer physical
health, psychological health and environment, but not social
relationships. Attention remained a predictor for psychologi-
cal health, social relationships, and environment when psy-
chological variables were added; however, reduction in the
estimate indicates that mood and fatigue may partially explain
this effect. Older age was related to better psychological health
and environment, but no association was found with physical
health and social relationships.
Discussion
Results of the current study indicate that between-subject dif-
ferences and within-subject changes in perceived concentra-
tion and attention in PCI patients over the first year post-PCI
were strongly associated with poorer HRQL during this time
Table 2 Results from multivariable linear mixed models for concentration problems total score





Concentration problems score Est. SEM p Est. SEM p Est. SEM p Est. SEM p Est. SEM p
Time (baseline, 1 year) 0.44 .088 <.001 1.00 .144 <.001 −0.07 .123 .581 −0.29 .172 .091 0.13 .121 .269
Step 1. Unadjusted model
Time (baseline, 1 year) 0.37 .111 <.001 1.00 .140 <.001 −0.07 .123 .596 −0.28 .174 .114 0.13 .122 .280
Concentration between −0.45 .042 <.001 −0.79 .069 <.001 −0.78 .062 <.001 −0.65 .074 <.001 −0.58 .067 <.001
Concentration within −0.12 .031 <.001 −0.33 .053 <.001 −0.20 .044 <.001 −0.13 .058 .028 −0.12 .041 .003
Step 2. Adjusted for demographic and clinical variables
Time (baseline, 1 year) 0.40 .091 <.001 0.94 .149 <.001 −0.14 .129 .266 −0.40 .181 .029 0.06 .129 .630
Concentration between −0.45 .045 <.001 −0.76 .074 <.001 −0.78 .068 <.001 −0.65 .079 <.001 −0.60 .071 <.001
Concentration within −0.13 .032 <.001 −0.32 .055 <.001 −0.21 .045 <.001 −0.15 .060 .014 −0.13 .043 .002
High education 0.50 .924 .592 0.44 .247 .078 0.19 .227 .394 0.40 .262 .130 1.05 .234 <.001
Male gender 0.17 .173 .328 0.89 .289 .002 0.54 .265 .043 −0.40 .305 .188 0.16 .273 .561
Acute PCI 0.10 .145 .476 0.39 .242 .108 0.16 .223 .479 0.82 .260 .002 0.09 .230 .695
Cardiac history −0.18 .159 .251 −0.22 .264 .398 −0.00 .242 .994 −0.11 .280 .704 −0.23 .250 .352
Antidepressant use −0.38 .325 .248 −1.03 .539 .057 −0.98 .497 .050 −0.45 .574 .430 0.13 .512 .804
Step 3. Adjusted for psychological variables (clinical + psychological variables)
Concentration between −0.18 .041 <.001 −0.29 .064 <.001 −0.41 .063 <.001 −0.35 .081 <.001 −0.38 .071 <.001
Concentration within −0.08 .030 .009 −0.22 .051 <.001 −0.13 .043 .002 −0.08 .060 .155 −0.09 .043 .041
Mood −0.10 .009 <.001 −0.12 .014 <.001 −0.15 .013 <.001 −0.13 .017 <.001 −0.09 .014 <.001
Fatigue −0.08 .012 <.001 −0.23 .020 <.001 −0.06 .018 .001 −0.04 .024 .102 −0.04 .019 .022
Step 4. Complete model (clinical + psychological variables + age)
Concentration between −0.16 .041 <.001 −0.30 .065 <.001 −0.39 .064 <.001 −0.35 .082 <.001 −0.35 .071 <.001
Concentration within −0.08 .030 .009 −0.23 .051 <.001 −0.13 .043 .003 −0.08 .060 .155 −0.09 .043 .045
Age 0.02 .006 .007 −0.01 .010 .251 0.03 .009 .004 0.00 .012 .873 0.03 .011 .006
Bold p values indicate statistical significance, italic p values indicate significance on a trend level
PCI percutaneous coronary intervention, QoL quality of life, Est, estimate, SEM standard error of the mean, a Score without concentration item
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period, independent of demographic and clinical covariates.
Contrary to between-subject differences in perceived
cognition, which were associated with all HRQL domains,
within-subject changes in perceived attention were not
General health and overall QoL









General health and overall QoL
















































































































Perceived AenonPerceived ConcentraonFig. 1 Health related quality of
life over time. HigherWHOQOL-
Bref scores denote better quality
of life; higher perceived
concentration/attention scores
denote more complaints. QoL
quality of life
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associated with psychological health, social relationships, and
environment over time. Depression and fatigue only partially
accounted for the longitudinal association between perceived
cognitive function and HRQL.
With respect to HRQL, the domains general health and
overall QoL and physical health improved over time in this
sample of PCI patients. This is in line with previous research
validating the benefit of PCI in CAD patients [1, 2]. However,
the scores of the domain social relationships tended to de-
crease in this population over time, indicating that 12 months
after undergoing a PCI, CAD patients may perceive less social
support.
Perceived cognitive complaints were associated with a de-
cline in multiple areas of HRQL, even after controlling for
factors that are known to be related to HRQL, which is in line
with a previous study in CABG patients [18]. This indicates
also that using a PCI control group to assess cognitive changes
after invasive cardiovascular treatment [3, 11, 13, 15, 18] may
be biasing the results, as the PCI group may be experiencing
complaints themselves. In contrast to other studies on the top-
ic, our study investigated both between- and within-subjects
effects. The strong association between the poorer person-
mean scores of participants on perceived cognition and poorer
HRQL might be explained by pre-existing cerebrovascular
abnormalities, such as white matter hyperintensities and
infarct-like lesions, which are common in CAD patients, and
associated with poorer cognitive functioning [8, 9]. Future
studies including, e.g., magnetic resonance imaging (MRI)
might be able to examine this explanation further. In addition,
it is of importance that perceived cognitive complaints are
included as an outcome variable in future studies, because
perceived cognitive complaints might predict the progression
of imminent cognitive decline [17]. Cognitive decline (i.e., the
within-subject change) is associatedwith less ability to engage
in activities of daily living [18], which may explain the asso-
ciation with a decline in HRQL. Several core executive func-
tions seem relevant for mental as well as physical HRQL, due
to the everyday life activities people undertake in which cog-
nitive functioning is needed (e.g., switching between tasks)
[28]. When these cognitive functions are limited, there is less
ability to engage in activities of daily living, thereby negative-
ly affecting HRQL [18]. Moreover, the independent
Table 3 Results from multivariable linear mixed models for attention problems total score
Attention problems scores General health and overall QoL Physical health Psychological healtha Social relationships Environment
Est. SEM p Est. SEM p Est. SEM p Est. SEM p Est. SEM p
Step 1. Unadjusted model
Time (baseline, 1 year) 0.39 .089 <.001 0.99 .147 <.001 −0.08 .127 .554 −0.25 .175 .147 0.15 .124 .234
Attention between −0.16 .023 <.001 −0.27 .039 <.001 −0.30 .035 <.001 −0.26 .039 <.001 −0.22 .036 <.001
Attention within −0.05 .016 .004 −0.06 .026 .018 −0.03 .022 .160 −0.01 .030 .770 −0.01 .021 .655
Step 2. Adjusted for demographic and clinical variables
Time (baseline, 1 year) 0.37 .093 <.001 0.94 .156 <.001 −0.16 .133 .237 −0.39 .184 .036 0.09 .132 .483
Attention between −0.15 .024 <.001 −0.25 .040 <.001 −0.29 .036 <.001 −0.28 .040 <.001 −0.23 .036 <.001
Attention within −0.06 .017 <.001 −0.07 .029 .012 −0.04 .024 .122 −0.01 .032 .675 −0.00 .023 .894
High education 0.28 .160 .080 0.51 .296 .058 0.33 .247 .178 0.50 .271 .066 1.16 .245 <.001
Male gender 0.11 .187 .565 0.67 .313 .033 0.31 .287 .278 −0.72 .316 .024 −0.03 .286 .923
Acute PCI 0.04 .155 .773 0.22 .261 .406 0.02 .239 .947 0.64 .263 .016 −0.05 .238 .831
Cardiac history −0.33 .169 .055 −0.40 .284 .160 −0.29 .260 .272 −0.33 .286 .255 −0.47 .259 .073
Antidepressant use −1.07 .334 .001 −2.21 .563 <.001 −2.19 .516 <.001 −1.47 .566 .010 −0.81 .513 .114
Step 3. Adjusted for psychological variables (clinical + psychological variables)
Attention between −0.04 .019 .028 −0.07 .031 .028 −0.14 .030 <.001 −0.16 .038 <.001 −0.14 .034 <.001
Attention within −0.04 .016 .011 −0.03 .030 .193 0.00 .023 .963 0.02 .031 .576 0.02 .023 .419
Mood −0.11 .009 <.001 −0.14 .015 <.001 −0.17 .013 <.001 −0.14 .017 <.001 −0.10 .014 <.001
Fatigue −0.09 .012 <.001 −0.25 .021 <.001 −0.07 .018 <.001 −0.04 .024 .076 −0.06 .019 .003
Step 4. Complete model (clinical + psychological variables + age)
Attention between −0.04 .019 .038 −0.07 .031 .026 −0.13 .030 .001 −0.16 .038 <.001 −0.13 .033 <.001
Attention within −0.04 .016 .013 −0.03 .026 .190 −0.00 .023 .908 0.02 .038 .567 0.02 .023 .380
Age 0.02 .006 .006 −0.00 .010 .606 0.03 .009 .001 0.01 .012 .524 0.04 .011 .001
Bold p values indicate statistical significance, italic p values indicate significance on a trend level
PCI percutaneous coronary intervention, QoL quality of life, Est. estimate, SEM standard error of the mean
a Score without concentration item
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relationship between mood, fatigue, and HRQL [29] might be
explained by limitations in daily functioning as well.
One important observed difference between attention and
concentration complaints was that changes in perceived atten-
tion complaints within a person did not relate to changes in
psychological health, social relationships or environment,
while within-subject differences in concentration complaints
were associated with all HRQL domains. An explanation
might be sought in differences in patient characteristics.
Patients with high perceived concentration complaints were
more likely to have undergone an acute PCI. In these acute
cases, patients were either in danger of cardiac arrest or were
experiencing myocardial infarction preceding the interven-
tion. Cardiac arrest might lead to oxygen deficiency in the
brain, a well-known cause of decline in cognitive functioning
[30]. Therefore, we might hypothesize that perceived atten-
tional complaints may have a different underlying cause than
perceived concentration complaints. For example, ruminative
trains of thought leading to disengagement of attention from
the momentary task or experience toward personally relevant
and negative material [31], may cause perceived attention
complaints rather than oxygen deficiency in the brain would
do. This would deserve further investigation in future studies.
The relation with poorer HRQL may be explained by disen-
gagement of attention and rumination being associated with
reduced mindfulness and well-being [32]. As a consequence
of the different results found between acute PCI and elective
PCI in relation to attention and concentration complaints, we
suggest that a differentiation between acute PCI and elective
PCI is warranted in future studies.
Depressive symptoms and fatigue partly accounted for the
effects of perceived cognitive complaints for all HRQL do-
mains although effects remained significant. Depressed mood
and fatigue have been associated with both CAD and cogni-
tion [21, 23, 33]. Not only does depressed mood increase the
risk of developing CAD [34], but both depressed mood and
fatigue are common in patients with CAD, which in turn is
associated with worsened outcome in CAD patients, including
decreased HRQL [21, 33–35]. Our results are in line with
prior findings showing perceived decline in cognitive func-
tioning to be higher in the subjects with higher depression
scores and lower ratings of subjective health [36], but also
clearly show the partial independence of perceived cognitive
function from these variables. Depressive symptoms and fa-
tigue remain important variables to take into consideration
when exploring the relationship between cognitive function-
ing and poor HRQL.
Our study suggests that older age is associated with better
general health and overall QoL, psychological health, and a
better environment. However, it hardly interfered with the
association between perceived cognition and HRQL, as worse
perceived cognition remained a predictor of poorer HRQL.
However, there seems to be an interaction, with the average
age being higher in the low perceived cognition complaints
group than the high perceived cognition complaints group. It
is possible that the greater burden of illness in participants of
working age has a more negative outcome on perceived cog-
nitive functioning in younger than in older study participants.
Older participants might perceive less cognitive change, due
to retirement and might therefore be less exposed to higher
cognitively demanding tasks. Evidence also suggests that
middle-aged CAD patients are more affected by emotional
distress than older-aged patients [37]. This is in line with the
current results showing that older age is associated with better
general health and overall QoL, psychological health, and
environment.
In a comparable study in CABG patients with similar re-
sults, cognition was assessed objectively using neuropsycho-
logical tests [18]. This is a frequently used method for
assessing cognition to detect impairments [6]. In our study,
participants reported on how they perceived attention and con-
centration. Some changes in cognition might not be measured
through objective tests, but still may be perceived by the pa-
tient. Another advantage for assessing perceived cognition is
that there is no sign of practice effects, which often happens
with objective tests that are repeated over time [38]. However,
further study is needed to examine whether and which other
components of cognition serve as potential predictors of
HRQL, and standardized neuropsychological tests might help
to further investigate this. In addition, it might be interesting to
study PCI patients in a longitudinal study in which standard-
ized neuropsychological tests are used to assess cognition in
order to see whether the same relationship is found between
objectively assessed cognition and HRQL.
From a clinical perspective, results may suggest that per-
ceived cognitive functioning and HRQL have had time to im-
prove in 1 year. The strong correlation of change in perceived
cognitive functioning with change in HRQL supports the im-
portance of addressing cognitive function when evaluating re-
covery from PCI. In addition, clinicians should evaluate cogni-
tion and consider including neurocognitive screening as part of
treatment after PCI, for example in cardiac rehabilitation [39].
There are several limitations that should be taken into con-
sideration. First, cognition was only assessed by means of self-
report, which may be subjected to systematic biases and may
not reflect neuropsychological dysfunction [36]. Perceived
cognition therefore may not give estimates of actual cognitive
skills, and lower cognition scores in the current study cannot be
interpreted as a decline in cognition, but rather how patients
perceive how their cognition has changed. Subjectively mea-
suring cognitive functioning might therefore be more associat-
ed with other processes, such as depressive mood, than objec-
tive assessment. Previous findings of Vingerhoets et al. report-
ed that high reported depression scores had no effect on cogni-
tive performance but did affect patients who subjectively felt
that their cognitive abilities were decreased [40]. Second,
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perceived concentration and attention complaints were not
assessed through an existing questionnaire, but through com-
bining items and facets from existing questionnaires. The
choice for the TFMQ-SF acting with awareness facet was made
because of its strong association with executive functioning
[41]. Further, by using the item for concentration from the
WHOQOL-bref domainBpsychological health,^ the items for
assessing concentration might be highly correlated with this
domain. In addition, this domain is therefore not comparable
to scores on this domain in other studies. Also, it is impossible
to know from this study whether these findings are unique for
post-PCI patients, due to the absence of a comparison group.
Moreover, the majority of our sample was treated acutely, mak-
ing it impossible to measure pre-PCI perceived cognition, and
therefore, it is impossible to know if patients’ self-perceived
cognition was any different prior to PCI. Because this is a
single-center study in PCI patients only, the generalizability
of the results to other PCI or other cardiac populations remains
unknown. Finally, 17% of the sample had dropped out or were
deceased at the 12-month measurement occasion, due to older
age, heart failure, and increased baseline depression. This
might have affected the results.
Strengths of this study were the relatively large sample size,
the longitudinal and multivariable design with time-varying
predictors, and co-variates. Previous studies have mentioned
the importance of including emotional factors [5, 42], so the
inclusion of psychological variables was another substantial
strength. Also, the current study was the first study to include
PCI patients as main group to investigate the relationship be-
tween cognition and HRQL over time. Further, our study dis-
tinguished between- and within-subjects effects, which makes
this the first study to examine whether changes within a per-
son were associated with changes in HRQL. Finally, the
Elisabeth-TweeSteden hospital is one of the largest PCI cen-
ters in the Netherlands, serving a cardiac population that is
representative of the cardiac population in the Netherlands.
To conclude, between-subject differences and within-
subject changes in perceived concentration and attention in
PCI patients were strongly associated with HRQL over time,
such that poorer perceived concentration and attention were
associated with poorer HRQL, independent of demographic,
and clinical variables. Mood and fatigue seemed to partially
account for these associations. Age did not interfere with the
association between perceived cognition and HRQL. Further
study is warranted on objective cognitive assessment in PCI
patients and the role of cognitive functioning on HRQL. We
would recommend clinicians to take cognitive functioning into
consideration as part of treatment and rehabilitation after PCI.
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